Prosecution Insights
Prosecution Insights
45 pending office actions • 28 art units • 42 examiners • 0 of 45 (0%) have an AI response strategy ready • 90 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 45 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 45 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (2%) |
| §103 only | 23 (51%) |
| §102 only | 2 (4%) |
| §112 only | 5 (11%) |
| No statute on record | 14 (31%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| COFFA, SERGIO | 2 | 61.0% | +33.3% |
| SZPERKA, MICHAEL EDWARD | 2 | 62.5% | +37.6% |
| ESPINOSA, CLAUDIA EDILMA | 2 | 53.2% | +58.5% |
| NOAKES, SUZANNE MARIE | 1 | 73.1% | +18.3% |
| SITTON, JEHANNE SOUAYA | 1 | 52.9% | +47.9% |
| HADDAD, MAHER M | 1 | 50.4% | +54.3% |
| HERNANDEZ, JACKSON J | 1 | 52.8% | +51.5% |
| NGUYEN, NGHI V | 1 | 53.6% | +50.4% |
| LAU, JONATHAN S | 1 | 63.8% | -18.5% |
| ROBINSON, MIKHAIL O'DONNEL | 1 | 56.8% | +41.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18557836 | METHOD FOR PRODUCING CELLS | NGUYEN, NGHI V | 28d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18535781 | VEDOLIZUMAB FOR THE TREATMENT OF FISTULIZING CROHN'S DISEASE | HADDAD, MAHER M | 121d overdue |
| 18550571 | PLASMA KALLIKREIN INHIBITORS | ROBINSON, MIKHAIL O'DONNEL | 79d overdue |
| 17554539 | QD DOSING OF GIP RECEPTOR AGONIST PEPTIDE COMPOUNDS AND USES THEREOF | ESPINOSA, CLAUDIA EDILMA | 73d overdue |
| 17556857 | PURIFICATION OF FVIII FROM PLASMA USING SILICON OXIDE ADSORPTION | ESPINOSA, CLAUDIA EDILMA | 66d overdue |
| 18557836 | METHOD FOR PRODUCING CELLS | NGUYEN, NGHI V | 28d overdue |
| 17264720 | FORMULATIONS FOR IMPROVED STABILITY OF RECOMBINANT HUMAN PARATHYROID HORMONE | COFFA, SERGIO | 17d overdue |
| 18030901 | THERAPEUTIC AGENT FOR IMMUNE/INFLAMMATORY DISEASE | SZPERKA, MICHAEL EDWARD | 8d |
| 17284291 | METHOD FOR PRODUCING ANTIBODY-DRUG CONJUGATE | SZPERKA, MICHAEL EDWARD | 26d |
| Art Unit | Apps |
|---|---|
| 1641 | 4 |
| 3783 | 4 |
| 1658 | 3 |
| 1654 | 3 |
| 1627 | 2 |
| 1622 | 2 |
| 1633 | 2 |
| 1647 | 2 |
| 1645 | 2 |
| 1657 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18545528 | REMOVAL OF SERINE PROTEASES BY TREATMENT WITH FINELY DIVIDED SILICON DIOXIDE | NOAKES, SUZANNE MARIE | 1656 | §102 | Final Rejection | 75d | Pending | Dec 19, 2023 |
| 18537204 | RNA BIOMARKERS FOR HEREDITARY ANGIOEDEMA | SITTON, JEHANNE SOUAYA | 1682 | §103 | Non-Final OA | 34d | Pending | Dec 12, 2023 |
| 18535781 | VEDOLIZUMAB FOR THE TREATMENT OF FISTULIZING CROHN'S DISEASE | HADDAD, MAHER M | 1641 | Other | Non-Final OA | 121d overdue | Pending | Dec 11, 2023 |
| 18522917 | HETEROCYCLIC COMPOUND AND USE THEREOF | HERNANDEZ, JACKSON J | 1627 | §112 | Non-Final OA | 56d | Pending | Nov 29, 2023 |
| 18557836 | METHOD FOR PRODUCING CELLS | NGUYEN, NGHI V | 1653 | §101 | Non-Final OA | 28d overdue | Pending | Oct 27, 2023 |
| 18379047 | VIRAL INHIBITORS, THE SYNTHESIS THEREOF, AND INTERMEDIATES THERETO | LAU, JONATHAN S | 1693 | Other | Non-Final OA | 9d | Pending | Oct 11, 2023 |
| 18550571 | PLASMA KALLIKREIN INHIBITORS | ROBINSON, MIKHAIL O'DONNEL | 1627 | Other | Non-Final OA | 79d overdue | Pending | Sep 14, 2023 |
| 18550486 | POLYCYCLIC INHIBITORS OF PLASMA KALLIKREIN | ELENISTE, PIERRE PAUL | 1622 | §102 | Non-Final OA | 69d | Pending | Sep 14, 2023 |
| 18547809 | COMPOSITION AND METHODS FOR THE TREATMENT OF FABRY DISEASE | POPA, ILEANA | 1633 | §103 | Non-Final OA | 70d overdue | Pending | Aug 24, 2023 |
| 18264150 | SUPPORT FIXTURE FOR CHROMATOGRAPHY COLUMNS | KRCHA, MATTHEW D | 1796 | §103 | Non-Final OA | 32d overdue | Pending | Aug 03, 2023 |
| 18266848 | CONDITIONALLY BISPECIFIC BINDING PROTEINS | BUTTICE, AUDREY L | 1647 | Other | Non-Final OA | 16d | Pending | Jun 13, 2023 |
| 18039137 | FLUID DELIVERY SYSTEM CONTAINER AND METHOD OF USE | FARRAR, LAUREN PENG | 3783 | §103 | Non-Final OA | 49d overdue | Pending | May 26, 2023 |
| 18037834 | FLUID DELIVERY DEVICES AND METHODS THEREOF | LANGE, ERIC A | 3783 | §103 | Non-Final OA | 28d overdue | Pending | May 19, 2023 |
| 18199216 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND USE OF SAME | KOSACK, JOSEPH R | 3991 | Other | Final Rejection | 88d overdue | Pending | May 18, 2023 |
| 18316988 | TREATMENT OF PATIENTS WITH SEVERE VON WILLEBRAND DISEASE UNDERGOING ELECTIVE SURGERY BY ADMINISTRATION OF RECOMBINANT VWF | COFFA, SERGIO | 1658 | Other | Final Rejection | 55d | Pending | May 12, 2023 |
| 18316151 | POOLING DEVICE FOR SINGLE OR MULTIPLE MEDICAL CONTAINERS | ZIMBOUSKI, ARIANA | 3781 | Other | Final Rejection | 8d overdue | Pending | May 11, 2023 |
| 18029026 | PARATHYROID GLAND CELLS | BEHARRY, ZANNA MARIA | 1632 | §103 | Non-Final OA | 24d overdue | Pending | Apr 11, 2023 |
| 18030901 | THERAPEUTIC AGENT FOR IMMUNE/INFLAMMATORY DISEASE | SZPERKA, MICHAEL EDWARD | 1641 | §112 | Non-Final OA | 8d | Pending | Apr 07, 2023 |
| 18025315 | SUBSTITUTED PYRIMIDINE DERIVATIVES AS NICOTINIC ACETYLCHOLINESTERASE RECEPTOR ALPHA 6 MODULATOR | SANCHEZ, JUSTIN CHRISTOPHER | 1622 | §112 | Non-Final OA | 76d | Pending | Mar 08, 2023 |
| 18022669 | INTERLEUKIN-2 MUTEINS AND USES THEREOF | GURLEY, JAMI MICHELLE | 1647 | §103 | Final Rejection | 6d | Pending | Feb 22, 2023 |
| 18160407 | LIBRARIES OF GENETIC PACKAGES COMPRISING NOVEL HC CDR1, CDR2, AND CDR3 AND NOVEL LC CDR1, CDR2, AND CDR3 DESIGNS | BOESEN, CHRISTIAN C | 1684 | Other | Non-Final OA | 29d | Pending | Jan 27, 2023 |
| 18046450 | FORMULATION FOR ANTI-ALPHA4BETA7 ANTIBODY | KIM, YUNSOO | 1641 | Other | Final Rejection | 54d | Pending | Oct 13, 2022 |
| 17995615 | NEEDLE CONNECTORS AND MODULAR NEEDLE CONNECTORS FOR MULTI-DOSE DRUG DELIVERY DEVICES AND METHODS THEREOF | GRASMEDER, SARAH DYMPNA | 3783 | §103 | Non-Final OA | 13d | Pending | Oct 06, 2022 |
| 17916441 | ADAMTS13 VARIANT, COMPOSITIONS, AND USES THEREOF | ROBINSON, HOPE A | 1652 | §112 | Final Rejection | 72d overdue | Pending | Sep 30, 2022 |
| 17995198 | Subcutaneous Port With Locking Member | STIGELL, THEODORE J | 3783 | §103 | Non-Final OA | 9d | Pending | Sep 30, 2022 |
| 17915940 | T CELL PROGENITOR PRODUCTION METHOD | PRONZATI, GINA | 1633 | §103 | Non-Final OA | 67d overdue | Pending | Sep 29, 2022 |
| 17906433 | IMPLANTABLE CELL CHAMBER DEVICE AND USES THEREOF | BECKHARDT, LYNDSEY MARIE | 1613 | §103 | Non-Final OA | 16d overdue | Pending | Sep 15, 2022 |
| 17778611 | T-CELL MASTER CELL BANK | ZHU, JIANJIAN | 1631 | Other | Final Rejection | 23d overdue | Pending | May 20, 2022 |
| 17745770 | PLASMA KALLIKREIN INHIBITORS AND USES THEREOF FOR TREATING HEREDITARY ANGIOEDEMA ATTACK | KOLKER, DANIEL E | 1645 | Other | Final Rejection | 44d overdue | Pending | May 16, 2022 |
| 17769452 | METHOD FOR EVALUATING DRUG TOXICITY | MARTIN, RACHEL E | 1657 | §103 | Non-Final OA | 127d overdue | Pending | Apr 15, 2022 |
| 17672748 | PLASMA KALLIKREIN INHIBITORS AND USES THEREOF FOR TREATING HEREDITARY ANGIOEDEMA ATTACK | OGUNBIYI, OLUWATOSIN A | 1645 | §103 | Non-Final OA | 51d overdue | Pending | Feb 16, 2022 |
| 17285397 | NUTRITION COMPOSITION | BAUER, NICOLA MARIA | 1621 | §103 | Non-Final OA | 131d overdue | Pending | Jan 14, 2022 |
| 17622580 | TRANSFECTION METHOD | MEJIAS, SAMANTHA LEE | 1618 | §103 | Final Rejection | 15d | Pending | Dec 23, 2021 |
| 17556857 | PURIFICATION OF FVIII FROM PLASMA USING SILICON OXIDE ADSORPTION | ESPINOSA, CLAUDIA EDILMA | 1654 | §103 | Non-Final OA | 66d overdue | Pending | Dec 20, 2021 |
| 17554539 | QD DOSING OF GIP RECEPTOR AGONIST PEPTIDE COMPOUNDS AND USES THEREOF | ESPINOSA, CLAUDIA EDILMA | 1654 | Other | Non-Final OA | 73d overdue | Pending | Dec 17, 2021 |
| 17596422 | ANTIBODY PURIFICATION METHODS AND COMPOSITIONS THEREOF | EDWARDS, JESSICA FAYE | 1657 | Other | Final Rejection | 23d | Pending | Dec 09, 2021 |
| 17596421 | METHODS OF PRODUCING AN ANTI-a4B7 ANTIBODY | FAUST, AMBER KATHLEEN | 1643 | §103 | Final Rejection | 8d overdue | Pending | Dec 09, 2021 |
| 17491813 | EVALUATION AND TREATMENT OF BRADYKININ-MEDIATED DISORDERS | PETRASH, HILARY ANN | 1644 | §112 | Non-Final OA | 8d | Pending | Oct 01, 2021 |
| 17362191 | METHODS OF PROPHYLACTIC TREATMENT USING RECOMBINANT VWF (rVWF) | AUDET, MAURY A | 1654 | §103 | Final Rejection | 79d | Pending | Jun 29, 2021 |
| 17284291 | METHOD FOR PRODUCING ANTIBODY-DRUG CONJUGATE | SZPERKA, MICHAEL EDWARD | 1641 | §103 | Final Rejection | 26d | Pending | Apr 09, 2021 |
| 17169835 | SEPARATION OF VWF AND VWF PROPEPTIDE BY CHROMATOGRAPHIC METHODS | STEELE, AMBER D | 1658 | Other | Non-Final OA | 89d overdue | Pending | Feb 08, 2021 |
| 17264720 | FORMULATIONS FOR IMPROVED STABILITY OF RECOMBINANT HUMAN PARATHYROID HORMONE | COFFA, SERGIO | 1658 | §103 | Final Rejection | 17d overdue | Pending | Jan 29, 2021 |
| 17263675 | METHOD FOR PRODUCING CD3-POSITIVE CELL | SHUPE, ELIZABETH A | 1643 | §103 | Non-Final OA | 19d | Pending | Jan 27, 2021 |
| 17041783 | SUBCUTANEOUS DOSING OF ANTI-CD38 ANTIBODIES | BENAVIDES, JENNIFER ANN | 1675 | §103 | Non-Final OA | 5d overdue | Pending | Sep 25, 2020 |
| 14407174 | LIQUID PREPARATIONS OF AMINES AND ORGANIC ACIDS STABILIZED BY SALTS | HAVLIN, ROBERT H | 1626 | §103 | Final Rejection | 70d overdue | Pending | Dec 11, 2014 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial